The Daily Papule

Meeting abstracts

PeDRA 2025

Pediatric Dermatology Research Alliance · Minneapolis, 9–11 October 2025

149 abstracts, published in JID on 9 March 2026. Their text is on the JID website.

  1. 001

    Diagnostic Challenges in Pediatric Hidradenitis Suppurativa: Hidden in Plain Sight

    Oladinni D, Tan I, … senior author Daveluy S

  2. 004

    Efficacy and safety of moxifloxacin in pediatric hidradenitis suppurativa: results from the Canadian Multidisciplinary Registry of Pediatric HS

    Rahmani A, Dienes S, … senior author Sibbald C

  3. 007

    TARCing the Trends: Serum CCL17 as a Predictive Marker in Pediatric Atopic Dermatitis

    Gupta I

  4. 008

    Safety of Live Vaccination in Pediatric Patients Receiving Dupilumab: A PeDRA Multicenter Retrospective Study

    Lee S, Waggett S, … senior author Lee LW

  5. 009

    Clinical characteristics and identified allergens of Mexican children with allergic contact dermatitis: A preliminary study

    Lomelí-Valdez R, Zúñiga-González MG, … senior author García-Romero MT

  6. 010

    Bibliometric Analysis of the Top 10 Most Burdensome Pediatric Skin Conditions in the Journal Pediatric Dermatology (2019—2024)

    Mackenzie E, Gelman B, … senior author Lalor L

  7. 012

    Association Between Autism Spectrum Disorder and Atopic Dermatitis in U.S. Children: A Cross-Sectional Analysis of the 2024 NHIS

    Shqair L, Aggarwal D, … senior author Schwager Z

  8. 013

    Assessing Topical Ruxolitinib for Atopic Dermatitis Across Age Groups: A Meta-Analysis of Pediatric and Adult Data

    Millan DM, Ghanem L, … senior author Chien P

  9. 015

    How Pediatric Eczema Flares Disrupt Education

    Nwozo E, Silberzweig A, … senior author Shah PR

  10. 016

    Comparing Food Allergies in Eczema Herpeticum vs Atopic Dermatitis Pediatric Patients

    Pham D, Channa I, Ong P

  11. 019

    Mixed methods analysis of emergent clinical infantile hemangioma teleconsultation questions from primary care providers to pediatric dermatologists: directions for educational outreach

    Warnken SG, Murthy A, … senior author Creighton EG

  12. 022

    Disparities in infantile hemangioma care based on area of deprivation index: a retrospective cohort study

    Servattalab S, Paz KB, … senior author Grenier PO

  13. 023

    Enhancing Shared Decision Making in Pediatric Dermatology: Investigating Family, Patient and Physician Preferences for Laser Treatment In Patients With Cutaneous Vascular Lesions

    Stevens C, Siegel J, Coughlin C

  14. 025

    Segmental Stiff Skin Syndrome: A Multicenter Retrospective Study of 26 Pediatric Patients

    Wang D, Almeida Gomes LL, … senior author Brandling-Bennett H

  15. 026

    Pediatric Lichen Sclerosus Research: A Bibliometric Analysis (2010—2025)

    Kamel L, Gandhi I, … senior author Fishman S

  16. 027

    Pediatric patients with Parry-Romberg syndrome or progressive hemifacial atrophy: clinical characteristics, evolution, and treatment

    Romero MG, Zuniga MG, … senior author Scheffler S

  17. 030

    Barriers to Treatment Adherence in Pediatric Scabies: A Systematic Review

    Silberzweig A, Fritts H, … senior author Shah PR

  18. 033

    Characterization and Outcomes of Pediatric SCARs: A Review of Inpatient Dermatology Consults at a Tertiary Care Center

    Elkhammas H, Chirumamilla V, … senior author Faith EF

  19. 034

    Breaking the Language Barrier in Pediatric Dermatologic Conditions Using ChatGPT

    Gandhi I, Adler R, … senior author Fishman S

  20. 035

    UV Index Exposure by Zip Code and Photoprotection Education in Children with Skin of Color

    Adler R, Silberzweig A, … senior author Shah P

  21. 037

    Psychodermatology: Exploring the Bidirectional Link Between Skin Conditions and Mental Health in Children

    Gupta I

  22. 040

    Gorlin Syndrome Alliance Patient Registry Yields Insights on Patients with Multiple Childhood BCCs

    Su CHJ, Clark A, … senior author Hawryluk E

  23. 042

    Longitudinal Preventative and Medical Care of Adolescents and Adults with EB

    Pol L, Horn K, … senior author Gorell E

  24. 052

    Psychosocial Impact of Severe Alopecia Areata in Children and Evidence-Based Support Strategies

    Oladinni D, Cook K, Sataray-Rodriguez A

  25. 053

    Improving Awareness and Utilization of Pediatric Wig Resources Through Provider and Family Education at Children’s Hospital of Orange County

    Onejeme C, Ewulu A, Buethe M

  26. 054

    School Lice Policies, Stigma, and the Role of Pediatric Dermatology

    Silberzweig A, Fritts H, … senior author Bridges AG

  27. 055

    Comprehensibility of Spanish Patient Education Materials for Pruritic Dermatoses: A Comparison Between the Society for Pediatric Dermatology and Artificial Intelligence

    Gandhi I, Correa T, … senior author Fishman S

  28. 056

    Pediatric Dermatitis Artefacta: A Systematic Review of Dermatological Features and Psychiatric Comorbidities

    de Santana de Jesus ACV, Putini Vieira AC, … senior author de Deus Nunes Junior EB

  29. 057

    Geographic Distribution and Rural Accessibility of General and Pediatric Dermatology in Canada: Geospatial Analysis and Review of the Literature

    Ameri K, Ramien M, … senior author Rehmus W

  30. 058

    The Use of Teledermatology in Pediatric Populations: Does it Really Work?

    Fritts H, Frasier K, Bridges AG

  31. 060

    Dedicated Direct-to-Dermatology Appointment Slots for Pediatric Emergency Department Use

    Moir A, Tam G, Rehmus W

  32. 061

    Artificial Intelligence in Dermatology: Addressing Gaps in Pediatric and Skin-of-Color Populations — A Focused Literature Review

    Arguelles J, Aguilar A, … senior author Vital T

  33. 062

    Improving Pediatric Dermatology Education on Skin of Color: A Resident-Led Quality Improvement Initiative

    Cardoso RB, Cooper Z, … senior author Kumar M

  34. 063

    Shining Light on Treatments: A Systematic Review of Existing Therapies for Pediatric Segmental Vitiligo

    Ghani H

  35. 064

    A combined study assessing the effect of race and ethnicity on parent perspectives of care provided by pediatric dermatology

    Sharma D, Goff R, … senior author Todd P

  36. 067

    Dupilumab Safety and Efficacy Up to 3 Years Across Racial Subgroups in Pediatric Patients Aged 6 Months to 11 Years With Atopic Dermatitis

    Siegfried E, Cork M, … senior author Nguyen T

  37. 068

    Pharmacokinetics (PK) and safety of tralokinumab in children (aged 6 to <12 years) with moderate-to-severe atopic dermatitis: an interim analysis of the TRAPEDS 1 phase 2 trial

    Cork M, de Graaf M, … senior author Eichenfield LF

  38. 069

    Lebrikizumab Improves Anxiety and Depression Symptoms of Adolescents With Moderate-to-Severe Atopic Dermatitis: Results From a 52-Week, Open-label, Phase 3 Study

    Geng B, Mehta V, … senior author Qiao M

  39. 070

    Growth Analysis in Children Aged Less Than 12 Years with Moderate-to-Severe Atopic Dermatitis

    Paller A, Geng B, … senior author Zhang A

  40. 073

    INTEGUMENT-INFANT: A Phase 2, 4-Week Open-Label Safety Study of Roflumilast Cream 0.05% in Infants Aged 3 Months to Less than 2 Years With Mild-to-Moderate Atopic Dermatitis

    Hebert AA, Eichenfield LF, … senior author Burnett P

  41. 074

    Efficacy of Apremilast in Pediatric Patients With Plaque Psoriasis According to Disease Duration in the SPROUT Randomized Controlled Trial

    Langley RG, Arkin LM, … senior author Paller AS

  42. 075

    Efficacy and Safety of Risankizumab in Pediatric Patients With Psoriasis: Results From the OptIMMize-1 Phase 3 Study

    Magnolo N, Lee LW, … senior author Paller AS

  43. 078

    Growth Improvement in Children Aged 6 to 11 Years with Severe Atopic Dermatitis Treated with Dupilumab Irrespective of Cumulative TCS Use

    Irvine A, Paller A, … senior author Cyr S

  44. 080

    ReInspire: A Phase 2 Study of Mutant-Selective PI3Kα Inhibitor, RLY-2608, in Adults and Children with PIK3CA-Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation

    Drolet B, Mack J, … senior author Crary SE

  45. 084

    Baricitinib Provides Higher Efficacy in Adolescents Relative to Adults With Alopecia Areata Despite More Severe Disease at Baseline: 36-Week Outcomes From BRAVE-AA Trials

    Passeron T, Arkin L, … senior author Craiglow B

  46. 085

    Leveraging Academic — Industry Collaborations to Deliver New Insights into Pediatric Skin & Medical Guidelines: Hope & Challenges

    Visscher M, Surushe A, Carr A

  47. 086

    Outcomes and Predictors of Success in Pediatric Hidradenitis Suppurativa Deroofing Procedures

    Chajecki A, Cotton C

  48. 088

    Marketing of Over-the-Counter Acne Products to Adolescents: An Analysis of Consumer Behavior, Digital Strategy, and Psychosocial Impact

    Fritts H, Frasier K, … senior author Madan RK

  49. 089

    Differences in Drug Survival of TNF-alpha inhibitors between Pediatric and Adult Hidradenitis Suppurativa Patients

    Guo R, Jaleel T, … senior author Kroshinsky D

  50. 090

    Assessing Endocrine Disease Risk in Pediatric Early-Onset Hidradenitis Suppurativa

    Gurram A, Ross L